Transaction by Persons Discharging Managerial Responsibilities
Disclosure Rule DTR 3.1.4
We hereby inform you that on 25 February 2010, the following Directors acquired an interest in the USD0.25 Ordinary Shares of AstraZeneca PLC. The interest arises as a result of the previously disclosed arrangements relating to the payment of annual bonuses whereby each individual is required to defer a portion of the bonus earned into shares for a period of three years. The shares were allocated at a price of 2817.5 pence per share. The individuals will become beneficially entitled to these shares on 25 February 2013.
Name |
Number of shares awarded |
Total interest in shares after this allocation |
Percentage of shares in issue |
D Brennan |
20,718 |
See below |
See below |
S Lowth |
9,760
|
150,003 |
0.01% |
Mr Brennan has interests in both the Ordinary Shares and the American Depositary Shares (ADSs) of AstraZeneca PLC. One ADS equals one Ordinary Share.
As a result of this transaction, Mr Brennan's interest is now 516,713 Ordinary Shares and 78,027 AstraZeneca ADSs, which together represent approximately 0.04% of the Company's issued ordinary capital.
A C N Kemp
Company Secretary
26 February 2010